MAPT and depressive symptom measurement: Beyond these Aβ-related effects, cross-sectional neuroimaging studies have also demonstrated higher tau burden in individuals with depressive symptoms (Gatchel et al., 2017), raising the possibility that depression may be linked not only to Aβ burden but also to tau pathology.